Ads
    Related paper
  1. Variability of arterial pressure and cardiac rhythm in patients with coronary heart disease and diabetes mellitus: Effect of sodium-glucose co-transporter 2 inhibitor
  2. Risk and Benefits of Canagliflozin, a New Sodium-Glucose Co-Transporter Type 2 Inhibitor, in the Treatment of type-2 Diabetes Mellitus
  3. HEART RATE AND ARTERIAL PRESSURE VARIABILITY INDICES IN PATIENTS WITH ARTERIAL HYPERTENSION IN GROUPS OF TREATMENT WITH BETA ADRENERGIC ANTAGONIST, INHIBITOR OF ANGIOTENSINCONVERTING ENZYME AND THEIR COMBINATIONS AND CLASSES OF ECG QRS COMPLEX DURATION
  4. The Emergence of Sodium glucose Co-transporter 2 Inhibitors as a Successful Agent for Management of Diabetes Mellitus
  5. Features of short-term variability of arterial pressure with different types of circadian rhythm in patients with hypertension disease who have suffered myocardial infarction
  6. Use Of Sodium - Glucose Co - Transporter - 2 Inhibitors In Hospitalized Patients With Acute Heart Failure
  7. PECULIARITIES OF VARIABILITY OF HEART RHYTHM IN PATIENTS WITH ARTERIAL HYPERTENSION
  8. Dynamics of Cardiohemodynamic Indicators, Profibrotic and Lipidogram Parameters in Patients with Chronic Heart Failure on Background of Coronary Heart Disease and Type 2 Diabetes Mellitus during Treatment with Blockers of Β-Adrenoreceptors
  9. PREDICTION OF AN ADVERSE OUTCOME OF CORONARY HEART DISEASE IN PATIENTS SUFFERING FROM TYPE 2 DIABETES MELLITUS
  10. The Prevalence of Heart Failure in Hospitalized Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease in Albania